Target intelligence / Profile preview

Protein angel homolog 2 (ANGEL2)

Target
ANGEL2
Molecular classification
Enzyme, RNA phosphatase, CCR4 family member (deadenylase but distinct from classical deadenylases)
01

Overview

Protein angel homolog 2 (ANGEL2) is a divergent member of the CCR4 family of deadenylases, functioning as an RNA phosphatase rather than a traditional deadenylase. ANGEL2 catalyzes the conversion of 2′,3′-cyclic phosphates on RNA molecules into 2′,3′-hydroxyl groups, a reaction required for proper tRNA maturation, recycling during cellular stress, and the unconventional splicing of select mRNAs such as X-box binding protein 1 (XBP1). Rather than shortening poly(A) tails like classical deadenylases, ANGEL2 specializes in preparing RNA ends for ligation and maturation. This activity supports essential RNA processing functions in both the mitochondrion and cytoplasm. Epigenetic dysregulation of ANGEL2 has been implicated as a biomarker in cervical carcinogenesis, highlighting its clinical relevance despite the absence of direct drug interactions or therapeutic targeting at present.

Other names
CCR4DKIAA0759LFLJ12793Ccr4dangel homolog 2 (Drosophila)protein angel homolog 2
02

Biological functions

RNA processing: Converts 2′,3′-cyclic phosphate termini on RNA into 2′,3′-hydroxyl groupstRNA maturation: Facilitates proper tRNA processing and recycling during ribosome stallingUnconventional mRNA splicing: Involved in processing transcripts such as X-box binding protein 1 (XBP1)Negative regulation of mitotic cell cycle: Contributes to cell cycle regulationmRNA stabilization: Involved in 3′-UTR-mediated mRNA stabilization
03

Disease associations

Cancer (altered epigenetic regulation detected in cervical carcinogenesis suggests prognostic relevance)
04

Biomarkers

Epigenetic changes in ANGEL2 have been proposed as biomarkers for cervical cancer

Beyond the preview

Go deeper on Protein angel homolog 2 (ANGEL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein angel homolog 2 (ANGEL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call